Stratos Wealth Advisors LLC Trims Stock Position in Cigna Group $CI

Stratos Wealth Advisors LLC lowered its stake in shares of Cigna Group (NYSE:CI) by 11.7% in the second quarter, HoldingsChannel.com reports. The institutional investor owned 1,266 shares of the health services provider’s stock after selling 167 shares during the period. Stratos Wealth Advisors LLC’s holdings in Cigna Group were worth $419,000 as of its most recent filing with the SEC.

Other institutional investors have also modified their holdings of the company. Modern Wealth Management LLC raised its stake in shares of Cigna Group by 91.3% during the 1st quarter. Modern Wealth Management LLC now owns 3,130 shares of the health services provider’s stock valued at $1,030,000 after buying an additional 1,494 shares during the last quarter. Janney Montgomery Scott LLC raised its stake in shares of Cigna Group by 3.9% during the 2nd quarter. Janney Montgomery Scott LLC now owns 35,943 shares of the health services provider’s stock valued at $11,882,000 after buying an additional 1,357 shares during the last quarter. Acadian Asset Management LLC raised its stake in shares of Cigna Group by 277.5% during the 1st quarter. Acadian Asset Management LLC now owns 8,274 shares of the health services provider’s stock valued at $2,718,000 after buying an additional 6,082 shares during the last quarter. Dynamic Technology Lab Private Ltd acquired a new stake in shares of Cigna Group during the 1st quarter valued at about $431,000. Finally, Pzena Investment Management LLC grew its position in shares of Cigna Group by 9.7% during the 2nd quarter. Pzena Investment Management LLC now owns 523,600 shares of the health services provider’s stock valued at $173,092,000 after acquiring an additional 46,140 shares during the period. Hedge funds and other institutional investors own 86.99% of the company’s stock.

Insider Activity at Cigna Group

In other news, insider Nicole S. Jones sold 28,526 shares of the business’s stock in a transaction that occurred on Friday, August 15th. The stock was sold at an average price of $300.00, for a total transaction of $8,557,800.00. Following the transaction, the insider directly owned 25,648 shares in the company, valued at $7,694,400. The trade was a 52.66% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, insider Brian C. Evanko sold 5,368 shares of the business’s stock in a transaction that occurred on Friday, October 3rd. The stock was sold at an average price of $300.00, for a total value of $1,610,400.00. Following the transaction, the insider owned 51,182 shares in the company, valued at approximately $15,354,600. This represents a 9.49% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders own 0.70% of the company’s stock.

Wall Street Analyst Weigh In

A number of research firms have recently commented on CI. Wolfe Research dropped their target price on Cigna Group from $345.00 to $325.00 and set an “outperform” rating on the stock in a research report on Wednesday, October 15th. Weiss Ratings restated a “hold (c+)” rating on shares of Cigna Group in a research report on Wednesday, October 8th. The Goldman Sachs Group began coverage on Cigna Group in a research report on Tuesday, October 14th. They set a “buy” rating and a $370.00 target price on the stock. Wall Street Zen cut Cigna Group from a “buy” rating to a “hold” rating in a research report on Friday, October 3rd. Finally, Wells Fargo & Company raised their target price on Cigna Group from $340.00 to $354.00 and gave the company an “equal weight” rating in a research report on Tuesday, October 7th. Two equities research analysts have rated the stock with a Strong Buy rating, sixteen have given a Buy rating and three have given a Hold rating to the company. Based on data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $369.89.

Cigna Group Trading Up 3.0%

CI stock opened at $299.81 on Monday. The company has a current ratio of 0.71, a quick ratio of 0.71 and a debt-to-equity ratio of 0.65. Cigna Group has a 12-month low of $256.89 and a 12-month high of $353.55. The stock has a market cap of $80.03 billion, a price-to-earnings ratio of 16.37, a PEG ratio of 0.88 and a beta of 0.45. The business’s 50-day moving average is $297.27 and its 200 day moving average is $307.91.

Cigna Group (NYSE:CI) last issued its earnings results on Thursday, July 31st. The health services provider reported $7.20 earnings per share for the quarter, topping the consensus estimate of $7.15 by $0.05. The business had revenue of $67.13 billion for the quarter, compared to analysts’ expectations of $62.61 billion. Cigna Group had a return on equity of 18.80% and a net margin of 1.92%.The business’s revenue for the quarter was up 11.0% compared to the same quarter last year. During the same period in the previous year, the firm posted $6.72 EPS. Cigna Group has set its FY 2025 guidance at 29.600- EPS. On average, sell-side analysts anticipate that Cigna Group will post 29.77 EPS for the current fiscal year.

Cigna Group Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Thursday, September 18th. Stockholders of record on Thursday, September 4th were issued a dividend of $1.51 per share. This represents a $6.04 annualized dividend and a dividend yield of 2.0%. The ex-dividend date was Thursday, September 4th. Cigna Group’s payout ratio is currently 32.97%.

About Cigna Group

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.